Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, November 22, 2019 · 502,959,986 Articles · 3+ Million Readers

Global immuno oncology assays market is expected to grow with a CAGR of 8.6% over the forecast period from 2019-2025

The report on the global immuno oncology assays market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global immuno oncology assays market to grow with a CAGR of 8.

/EIN News/ -- New York, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Immuno Oncology Assays Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" - https://www.reportlinker.com/p05796558/?utm_source=GNW
6% over the forecast period from 2019-2025. The study on immuno oncology assays market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on immuno oncology assays market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global immuno oncology assays market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global immuno oncology assays market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Growing incidence of cancerous disease in the developing countries
• Growing government support to provide modern healthcare facilities to its people
2) Restraints
• Lack of healthcare professionals in the emerging countries
3) Opportunities
• The growing demand for better treatment for the cancer-related problem in the developing countries

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global immuno oncology assays market is segmented on the basis of product, technology, indication, and application.

The Global Immuno Oncology Assays Market by Product
• Consumables
• Software

The Global Immuno Oncology Assays Market by Technology
• PCR
• Immunoassay
• NGS
• Flow Cytometry
• Other Technology

The Global Immuno Oncology Assays Market by Indication
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Bladder Cancer
• Other Indication

The Global Immuno Oncology Assays Market by Application
• Research Applications
• Clinical Diagnostics

Company Profiles
• PerkinElmer, Inc.
• HTG Molecular Diagnostics, Inc.
• Foundation Medicine, Inc.
• Sartorius AG
• NanoString Technologies, Inc.
• Agilent Technologies
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific
• Illumina, Inc.
• QIAGEN GmbH

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the immuno oncology assays market.
2. Complete coverage of all the segments in the immuno oncology assays market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global immuno oncology assays market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Read the full report: https://www.reportlinker.com/p05796558/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
                    US: (339)-368-6001
                    Intl: +1 339-368-6001
Powered by EIN News
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release